BRIEF-Opiant Pharmaceuticals Reports Q1 Loss Per Share $3.68

May 8 (Reuters) - Opiant Pharmaceuticals Inc:

* OPIANT PHARMACEUTICALS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 LOSS PER SHARE $3.68

* QTRLY TOTAL REVENUE $1.7 MILLION VERSUS $11,000 Source text for Eikon: Further company coverage: